Amebiasis Therapeutics
Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms o ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Amebiasis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Metronidazole 1.2.3 Paromomycin 1.2.4 Tinidazole 1.2.5 Other 1.3 Market by Application 1.3.1 Global Amebiasis Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Amebiasis Treatment Market Perspective (2016-2027) 2.2 Amebiasis Treatment Growth Trends by Regions 2.2.1 Amebiasis Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Amebiasis Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Amebiasis Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Amebiasis Treatment Industry Dynamic 2.3.1 Amebiasis Treatment Market Trends 2.3.2 Amebiasis Treatment Market Drivers 2.3.3 Amebiasis Treatment Market Challenges 2.3.4 Amebiasis Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Amebiasis Treatment Players by Revenue 3.1.1 Global Top Amebiasis Treatment Players by Revenue (2016-2021) 3.1.2 Global Amebiasis Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Amebiasis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Amebiasis Treatment Revenue 3.4 Global Amebiasis Treatment Market Concentration Ratio 3.4.1 Global Amebiasis Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Amebiasis Treatment Revenue in 2020 3.5 Amebiasis Treatment Key Players Head office and Area Served 3.6 Key Players Amebiasis Treatment Product Solution and Service 3.7 Date of Enter into Amebiasis Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Amebiasis Treatment Breakdown Data by Type 4.1 Global Amebiasis Treatment Historic Market Size by Type (2016-2021) 4.2 Global Amebiasis Treatment Forecasted Market Size by Type (2022-2027) 5 Amebiasis Treatment Breakdown Data by Application 5.1 Global Amebiasis Treatment Historic Market Size by Application (2016-2021) 5.2 Global Amebiasis Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Amebiasis Treatment Market Size (2016-2027) 6.2 North America Amebiasis Treatment Market Size by Type 6.2.1 North America Amebiasis Treatment Market Size by Type (2016-2021) 6.2.2 North America Amebiasis Treatment Market Size by Type (2022-2027) 6.2.3 North America Amebiasis Treatment Market Size by Type (2016-2027) 6.3 North America Amebiasis Treatment Market Size by Application 6.3.1 North America Amebiasis Treatment Market Size by Application (2016-2021) 6.3.2 North America Amebiasis Treatment Market Size by Application (2022-2027) 6.3.3 North America Amebiasis Treatment Market Size by Application (2016-2027) 6.4 North America Amebiasis Treatment Market Size by Country 6.4.1 North America Amebiasis Treatment Market Size by Country (2016-2021) 6.4.2 North America Amebiasis Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Amebiasis Treatment Market Size (2016-2027) 7.2 Europe Amebiasis Treatment Market Size by Type 7.2.1 Europe Amebiasis Treatment Market Size by Type (2016-2021) 7.2.2 Europe Amebiasis Treatment Market Size by Type (2022-2027) 7.2.3 Europe Amebiasis Treatment Market Size by Type (2016-2027) 7.3 Europe Amebiasis Treatment Market Size by Application 7.3.1 Europe Amebiasis Treatment Market Size by Application (2016-2021) 7.3.2 Europe Amebiasis Treatment Market Size by Application (2022-2027) 7.3.3 Europe Amebiasis Treatment Market Size by Application (2016-2027) 7.4 Europe Amebiasis Treatment Market Size by Country 7.4.1 Europe Amebiasis Treatment Market Size by Country (2016-2021) 7.4.2 Europe Amebiasis Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Amebiasis Treatment Market Size (2016-2027) 8.2 Asia-Pacific Amebiasis Treatment Market Size by Type 8.2.1 Asia-Pacific Amebiasis Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Amebiasis Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Amebiasis Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Amebiasis Treatment Market Size by Application 8.3.1 Asia-Pacific Amebiasis Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Amebiasis Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Amebiasis Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Amebiasis Treatment Market Size by Region 8.4.1 Asia-Pacific Amebiasis Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Amebiasis Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Amebiasis Treatment Market Size (2016-2027) 9.2 Latin America Amebiasis Treatment Market Size by Type 9.2.1 Latin America Amebiasis Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Amebiasis Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Amebiasis Treatment Market Size by Type (2016-2027) 9.3 Latin America Amebiasis Treatment Market Size by Application 9.3.1 Latin America Amebiasis Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Amebiasis Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Amebiasis Treatment Market Size by Application (2016-2027) 9.4 Latin America Amebiasis Treatment Market Size by Country 9.4.1 Latin America Amebiasis Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Amebiasis Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Amebiasis Treatment Market Size (2016-2027) 10.2 Middle East & Africa Amebiasis Treatment Market Size by Type 10.2.1 Middle East & Africa Amebiasis Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Amebiasis Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Amebiasis Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Amebiasis Treatment Market Size by Application 10.3.1 Middle East & Africa Amebiasis Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Amebiasis Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Amebiasis Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Amebiasis Treatment Market Size by Country 10.4.1 Middle East & Africa Amebiasis Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Amebiasis Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Dr. Reddy’s Laboratories 11.1.1 Dr. Reddy’s Laboratories Company Details 11.1.2 Dr. Reddy’s Laboratories Business Overview 11.1.3 Dr. Reddy’s Laboratories Amebiasis Treatment Introduction 11.1.4 Dr. Reddy’s Laboratories Revenue in Amebiasis Treatment Business (2016-2021) 11.1.5 Dr. Reddy’s Laboratories Recent Development 11.2 Mission Pharmacal 11.2.1 Mission Pharmacal Company Details 11.2.2 Mission Pharmacal Business Overview 11.2.3 Mission Pharmacal Amebiasis Treatment Introduction 11.2.4 Mission Pharmacal Revenue in Amebiasis Treatment Business (2016-2021) 11.2.5 Mission Pharmacal Recent Development 11.3 Aceto Corporation 11.3.1 Aceto Corporation Company Details 11.3.2 Aceto Corporation Business Overview 11.3.3 Aceto Corporation Amebiasis Treatment Introduction 11.3.4 Aceto Corporation Revenue in Amebiasis Treatment Business (2016-2021) 11.3.5 Aceto Corporation Recent Development 11.4 Mylan Pharmaceuticals 11.4.1 Mylan Pharmaceuticals Company Details 11.4.2 Mylan Pharmaceuticals Business Overview 11.4.3 Mylan Pharmaceuticals Amebiasis Treatment Introduction 11.4.4 Mylan Pharmaceuticals Revenue in Amebiasis Treatment Business (2016-2021) 11.4.5 Mylan Pharmaceuticals Recent Development 11.5 Impax Laboratories 11.5.1 Impax Laboratories Company Details 11.5.2 Impax Laboratories Business Overview 11.5.3 Impax Laboratories Amebiasis Treatment Introduction 11.5.4 Impax Laboratories Revenue in Amebiasis Treatment Business (2016-2021) 11.5.5 Impax Laboratories Recent Development 11.6 Pfizer 11.6.1 Pfizer Company Details 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Amebiasis Treatment Introduction 11.6.4 Pfizer Revenue in Amebiasis Treatment Business (2016-2021) 11.6.5 Pfizer Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Details 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Amebiasis Treatment Introduction 11.7.4 Sanofi Revenue in Amebiasis Treatment Business (2016-2021) 11.7.5 Sanofi Recent Development 11.8 Lupin Pharmaceuticals 11.8.1 Lupin Pharmaceuticals Company Details 11.8.2 Lupin Pharmaceuticals Business Overview 11.8.3 Lupin Pharmaceuticals Amebiasis Treatment Introduction 11.8.4 Lupin Pharmaceuticals Revenue in Amebiasis Treatment Business (2016-2021) 11.8.5 Lupin Pharmaceuticals Recent Development 11.9 Glenmark Pharmaceuticals 11.9.1 Glenmark Pharmaceuticals Company Details 11.9.2 Glenmark Pharmaceuticals Business Overview 11.9.3 Glenmark Pharmaceuticals Amebiasis Treatment Introduction 11.9.4 Glenmark Pharmaceuticals Revenue in Amebiasis Treatment Business (2016-2021) 11.9.5 Glenmark Pharmaceuticals Recent Development 11.10 Sun Pharmaceutical 11.10.1 Sun Pharmaceutical Company Details 11.10.2 Sun Pharmaceutical Business Overview 11.10.3 Sun Pharmaceutical Amebiasis Treatment Introduction 11.10.4 Sun Pharmaceutical Revenue in Amebiasis Treatment Business (2016-2021) 11.10.5 Sun Pharmaceutical Recent Development 11.11 Heritage Pharmaceuticals 11.11.1 Heritage Pharmaceuticals Company Details 11.11.2 Heritage Pharmaceuticals Business Overview 11.11.3 Heritage Pharmaceuticals Amebiasis Treatment Introduction 11.11.4 Heritage Pharmaceuticals Revenue in Amebiasis Treatment Business (2016-2021) 11.11.5 Heritage Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Amebiasis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Metronidazole Table 3. Key Players of Paromomycin Table 4. Key Players of Tinidazole Table 5. Key Players of Other Table 6. Global Amebiasis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Amebiasis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Amebiasis Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Amebiasis Treatment Market Share by Regions (2016-2021) Table 10. Global Amebiasis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Amebiasis Treatment Market Share by Regions (2022-2027) Table 12. Amebiasis Treatment Market Trends Table 13. Amebiasis Treatment Market Drivers Table 14. Amebiasis Treatment Market Challenges Table 15. Amebiasis Treatment Market Restraints Table 16. Global Amebiasis Treatment Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Amebiasis Treatment Market Share by Players (2016-2021) Table 18. Global Top Amebiasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amebiasis Treatment as of 2020) Table 19. Ranking of Global Top Amebiasis Treatment Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Amebiasis Treatment Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Amebiasis Treatment Product Solution and Service Table 23. Date of Enter into Amebiasis Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Amebiasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 26. Global Amebiasis Treatment Revenue Market Share by Type (2016-2021) Table 27. Global Amebiasis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Amebiasis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Amebiasis Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Amebiasis Treatment Revenue Market Share by Application (2016-2021) Table 31. Global Amebiasis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Amebiasis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Amebiasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 34. North America Amebiasis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Amebiasis Treatment Market Size by Application (2016-2021) (US$ Million) Table 36. North America Amebiasis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Amebiasis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Amebiasis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Amebiasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Amebiasis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Amebiasis Treatment Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Amebiasis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Amebiasis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Amebiasis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Amebiasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Amebiasis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Amebiasis Treatment Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Amebiasis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Amebiasis Treatment Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Amebiasis Treatment Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Amebiasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Amebiasis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Amebiasis Treatment Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Amebiasis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Amebiasis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Amebiasis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Amebiasis Treatment Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Amebiasis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Amebiasis Treatment Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Amebiasis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Amebiasis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Amebiasis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 63. Dr. Reddy’s Laboratories Company Details Table 64. Dr. Reddy’s Laboratories Business Overview Table 65. Dr. Reddy’s Laboratories Amebiasis Treatment Product Table 66. Dr. Reddy’s Laboratories Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 67. Dr. Reddy’s Laboratories Recent Development Table 68. Mission Pharmacal Company Details Table 69. Mission Pharmacal Business Overview Table 70. Mission Pharmacal Amebiasis Treatment Product Table 71. Mission Pharmacal Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 72. Mission Pharmacal Recent Development Table 73. Aceto Corporation Company Details Table 74. Aceto Corporation Business Overview Table 75. Aceto Corporation Amebiasis Treatment Product Table 76. Aceto Corporation Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 77. Aceto Corporation Recent Development Table 78. Mylan Pharmaceuticals Company Details Table 79. Mylan Pharmaceuticals Business Overview Table 80. Mylan Pharmaceuticals Amebiasis Treatment Product Table 81. Mylan Pharmaceuticals Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 82. Mylan Pharmaceuticals Recent Development Table 83. Impax Laboratories Company Details Table 84. Impax Laboratories Business Overview Table 85. Impax Laboratories Amebiasis Treatment Product Table 86. Impax Laboratories Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 87. Impax Laboratories Recent Development Table 88. Pfizer Company Details Table 89. Pfizer Business Overview Table 90. Pfizer Amebiasis Treatment Product Table 91. Pfizer Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 92. Pfizer Recent Development Table 93. Sanofi Company Details Table 94. Sanofi Business Overview Table 95. Sanofi Amebiasis Treatment Product Table 96. Sanofi Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 97. Sanofi Recent Development Table 98. Lupin Pharmaceuticals Company Details Table 99. Lupin Pharmaceuticals Business Overview Table 100. Lupin Pharmaceuticals Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 101. Lupin Pharmaceuticals Recent Development Table 102. Glenmark Pharmaceuticals Company Details Table 103. Glenmark Pharmaceuticals Business Overview Table 104. Glenmark Pharmaceuticals Amebiasis Treatment Product Table 105. Glenmark Pharmaceuticals Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 106. Glenmark Pharmaceuticals Recent Development Table 107. Sun Pharmaceutical Company Details Table 108. Sun Pharmaceutical Business Overview Table 109. Sun Pharmaceutical Amebiasis Treatment Product Table 110. Sun Pharmaceutical Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 111. Sun Pharmaceutical Recent Development Table 112. Heritage Pharmaceuticals Company Details Table 113. Heritage Pharmaceuticals Business Overview Table 114. Heritage Pharmaceuticals Amebiasis Treatment Product Table 115. Heritage Pharmaceuticals Revenue in Amebiasis Treatment Business (2016-2021) & (US$ Million) Table 116. Heritage Pharmaceuticals Recent Development Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global Amebiasis Treatment Market Share by Type: 2020 VS 2027 Figure 2. Metronidazole Features Figure 3. Paromomycin Features Figure 4. Tinidazole Features Figure 5. Other Features Figure 6. Global Amebiasis Treatment Market Share by Application: 2020 VS 2027 Figure 7. Hospital Case Studies Figure 8. Pharmacy Case Studies Figure 9. Amebiasis Treatment Report Years Considered Figure 10. Global Amebiasis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Amebiasis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Amebiasis Treatment Market Share by Regions: 2020 VS 2027 Figure 13. Global Amebiasis Treatment Market Share by Regions (2022-2027) Figure 14. Global Amebiasis Treatment Market Share by Players in 2020 Figure 15. Global Top Amebiasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amebiasis Treatment as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Amebiasis Treatment Revenue in 2020 Figure 17. Global Amebiasis Treatment Revenue Market Share by Type (2016-2021) Figure 18. Global Amebiasis Treatment Revenue Market Share by Type (2022-2027) Figure 19. North America Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Amebiasis Treatment Market Share by Type (2016-2027) Figure 21. North America Amebiasis Treatment Market Share by Application (2016-2027) Figure 22. North America Amebiasis Treatment Market Share by Country (2016-2027) Figure 23. United States Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Amebiasis Treatment Market Share by Type (2016-2027) Figure 27. Europe Amebiasis Treatment Market Share by Application (2016-2027) Figure 28. Europe Amebiasis Treatment Market Share by Country (2016-2027) Figure 29. Germany Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Amebiasis Treatment Market Share by Type (2016-2027) Figure 37. Asia-Pacific Amebiasis Treatment Market Share by Application (2016-2027) Figure 38. Asia-Pacific Amebiasis Treatment Market Share by Region (2016-2027) Figure 39. China Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Amebiasis Treatment Market Share by Type (2016-2027) Figure 47. Latin America Amebiasis Treatment Market Share by Application (2016-2027) Figure 48. Latin America Amebiasis Treatment Market Share by Country (2016-2027) Figure 49. Mexico Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Amebiasis Treatment Market Share by Type (2016-2027) Figure 53. Middle East & Africa Amebiasis Treatment Market Share by Application (2016-2027) Figure 54. Middle East & Africa Amebiasis Treatment Market Share by Country (2016-2027) Figure 55. Turkey Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Amebiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Dr. Reddy’s Laboratories Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 59. Mission Pharmacal Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 60. Aceto Corporation Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 61. Mylan Pharmaceuticals Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 62. Impax Laboratories Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 63. Pfizer Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 64. Sanofi Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 65. Lupin Pharmaceuticals Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 66. Glenmark Pharmaceuticals Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 67. Sun Pharmaceutical Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 68. Heritage Pharmaceuticals Revenue Growth Rate in Amebiasis Treatment Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed
Dr. Reddy’s Laboratories Mission Pharmacal Aceto Corporation Mylan Pharmaceuticals Impax Laboratories Pfizer Sanofi Lupin Pharmaceuticals Glenmark Pharmaceuticals Sun Pharmaceutical Heritage Pharmaceuticals
Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms o ... Read More
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot ... Read More
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of u ... Read More
Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL), and one of th ... Read More